Association of Frailty with Adverse Outcomes in Patients with Suspected COVID-19 Infection

por Simon, Noemi R., Jauslin, Andrea S., Rueegg, Marco, Twerenbold, Raphael, Lampart, Maurin, Osswald, Stefan, Bassetti, Stefano, Tschudin-Sutter, Sarah, Siegemund, Martin, Nickel, Christian H., Bingisser, Roland
Publicado 2021

Direct Comparison of Clinical Characteristics, Outcomes, and Risk Prediction in Patients with COVID-19 and Controls—A Prospective Cohort Study

por Lampart, Maurin, Rüegg, Marco, Jauslin, Andrea S., Simon, Noemi R., Zellweger, Núria, Eken, Ceylan, Tschudin-Sutter, Sarah, Bassetti, Stefano, Rentsch, Katharina M., Siegemund, Martin, Bingisser, Roland, Nickel, Christian H., Osswald, Stefan, Kuster, Gabriela M., Twerenbold, Raphael
Publicado 2021

Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial

por Barco, Stefano, Voci, Davide, Held, Ulrike, Sebastian, Tim, Bingisser, Roland, Colucci, Giuseppe, Duerschmied, Daniel, Frenk, André, Gerber, Bernhard, Götschi, Andrea, Konstantinides, Stavros V, Mach, François, Robert-Ebadi, Helia, Rosemann, Thomas, Simon, Noemi R, Spechbach, Hervé, Spirk, David, Stortecky, Stefan, Vaisnora, Lukas, Righini, Marc, Kucher, Nils
Publicado 2022

Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial

por Voci, Davide, Götschi, Andrea, Held, Ulrike, Bingisser, Roland, Colucci, Giuseppe, Duerschmied, Daniel, Fumagalli, Riccardo M., Gerber, Bernhard, Hasse, Barbara, Keller, Dagmar I., Konstantinides, Stavros V., Mach, François, Rampini, Silvana K., Righini, Marc, Robert-Ebadi, Helia, Rosemann, Thomas, Roth-Zetzsche, Stéphanie, Sebastian, Tim, Simon, Noemi R., Spirk, David, Stortecky, Stefan, Vaisnora, Lukas, Kucher, Nils, Barco, Stefano
Publicado 2023